Resources Management Corp’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$312K Sell
6,500
-6,500
-50% -$279K 0.04% 164
2026
Q1
$478K Hold
13,000
0.06% 141
2025
Q4
$661K Sell
13,000
-325
-2% -$16.6K 0.09% 128
2025
Q3
$739K Sell
13,325
-575
-4% -$33.7K 0.1% 123
2025
Q2
$959K Sell
13,900
-950
-6% -$64.6K 0.13% 120
2025
Q1
$1.03M Sell
14,850
-250
-2% -$20.6K 0.15% 114
2024
Q4
$1.3M Hold
15,100
0.18% 102
2024
Q3
$1.8M Sell
15,100
-350
-2% -$46.7K 0.24% 85
2024
Q2
$2.21M Sell
15,450
-50
-0.3% -$6.63K 0.32% 71
2024
Q1
$1.99M Sell
15,500
-108
-0.7% -$12.9K 0.29% 76
2023
Q4
$1.61M Hold
15,608
0.24% 85
2023
Q3
$1.42M Buy
+15,608
New +$1.37M 0.23% 86

Other funds holding NVO

Resources Management Corp's NVO Position: Q2 2026 in Review

Resources Management Corp reduced its Novo Nordisk (NVO) stake by 50% in Q2 2026, selling an estimated $279K and leaving 6,500 shares worth $312K. The position accounts for 0.04% of the portfolio, ranked #164.

Resources Management Corp first reported a position in NVO in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.21M in Q2 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Resources Management Corp held 6,500 shares of Novo Nordisk worth $312K as of Q2 2026.
  • Resources Management Corp sold 6,500 Novo Nordisk shares in Q2 2026, an estimated $279K.
  • Novo Nordisk made up 0.04% of Resources Management Corp's portfolio in Q2 2026, its #164 holding.
  • Resources Management Corp first reported a position in Novo Nordisk in Q3 2023 and has held it in 12 quarters since.
  • Resources Management Corp's Novo Nordisk position peaked at $2.21M in Q2 2024.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Resources Management Corp's 13F filing for Q2 2026, filed 14 Aug 2026.